IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM?

by V. V. Omelyanovskiy
Published 2015-05-01

PROBLEMS OF OUTCOMES CHOICE FOR THE ASSESSMENT OF REHABILITATION PROGRAMS EFFICIENCY IN PATIENTS AFTER STROKE AND CRANIOCEREBRAL INJURY

by V. S. Dombrovskiy, V. V. Omelyanovskiy
Published 2015-03-01

LEGAL REGULATION OF STATE MANAGEMENT OF MEDICAL SCIENCE

by L. S. Melnikova, O. Yu. Rebrova, V. V. Omelyanovskiy
Published 2015-12-01

PARAMETERS OF HEALTH CARE SYSTEMS

by V. V. Omelyanovskiy, I. V. Maksimova, A. P. Tatarinov
Published 2015-03-01

EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS

by N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova
Published 2016-12-01

Organizational structure and funding of health technology assessment agencies around the world

by G. R. Khachatryan, V. V. Omelyanovskiy, L. S. Melnikova, S. S. Ratushnyak
Published 2019-07-01

Evaluation of the antitumor drugs therapeutic value using the method of multicriterial analysis of decision-making

by V. A. Lemeshko, N. Z. Musina, V. V. Omelyanovskiy
Published 2020-11-01

APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES

by V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova
Published 2015-05-01

GOVERNMENTAL FUNDING OF BIOMEDICAL RESEARCH IN THE UNITED STATES OF AMERICA, GREAT BRITAIN AND GERMANY

by G. R. Khachatrtyan, O. Yu. Rebrova, V. V. Omelyanovskiy
Published 2015-12-01

The health technology assessment system in Australia

by V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
Published 2020-02-01

Health technology assessment and reimbursement of pharmaceuticals in Italy

by F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
Published 2019-07-01

ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION

by M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva
Published 2015-03-01

ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS

by M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva
Published 2015-05-01

Drug provision and health technology assessment in France

by V. V. Omelyanovskiy, A. V. Nikitina, V. A. Lemeshko, G. R. Khachatryan
Published 2020-04-01

Evolution of healthcare provider payment mechanisms

by V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina
Published 2020-02-01

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE

by V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko
Published 2016-01-01

COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE

by V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko
Published 2016-01-01

Organization and financial support of healthcare for public employees in the Russian Federation: a review of departmental health services in the Ministry of Defense

by D. V. Lukyantseva, L. S. Melnikova, D. V. Fedyaev, T. P. Bezdenezhnykh, V. V. Omelyanovskiy
Published 2019-01-01

Regulatory framework of the oncological medical care provision

by S. N. Tishkina, V. E. Matskevich, Yu. A. Ledovskikh, E. V. Semakova, V. V. Omelyanovskiy
Published 2020-11-01

The review of the foreign experience on the financing of innovative medical technologies

by V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev
Published 2020-11-01